Statement from TAG, Global TB CAB on H56:IC31 Phase IIb trial results

The Global TB CAB and TAG commend the investigators for sharing results early and openly with a diverse group of key stakeholders, and urge the scientific community and funders to continue efforts to find different options to prevent TB.

Read More →

Development of the candidate TB vaccine H56:IC31 ended based on early data from the Prevention of Recurrence TB Consortium

Vaccine well tolerated and demonstrated immunogenicity but did not provide protection against TB recurrence; Participants being informed; Further analysis continues.

Read More →

Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research

A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.

Read More →

Stop TB Partnership announces the Legal Environment and Human Rights Scorecard

The Scorecard aims to enhance visibility and multisectoral accountability regarding legal, policy and human rights barriers experienced by people affected by TB.

Read More →

Country share of global 2023 UNHLM targets

The Stop TB Partnership releases the estimated country shares of global targets committed in the Political declaration of the UN High-Level Meeting on TB, held in September 2023.

Read More →

Report: TB Research Funding Trends 2005-2022

TB research and development funding perilously off track of UN commitments to end TB by 2030.

Read More →

TAG's 2023 Pipeline Report: TB Diagnostics

Treatment Action Group launches the 2023 Tuberculosis Diagnostics Pipeline Report.

Read More →

Technical brief: Access to TB testing and treatments: GeneXpert and delamanid

Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.

Read More →

Survey: Core outcome set for Phase 3 studies of pulmonary TB treatment

An international survey seeks to determine the most important outcomes to measure in Phase 3 trials of pulmonary TB treatment.

Read More →

TB REACH Wave 11 now open for proposals

The TB REACH Wave 11 call for proposals is focused on innovative approaches to integrate TB service delivery with lung health at the primary and community level of the health systems.

Read More →

Page 2 of 130 · Total posts: 10

←First 1 2 3 Last→